Biotech Blog

Journal of Commercial Biotechnology — November 2011 issue now available

October 28, 2011

The November 2011 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper: Journal of Commercial Biotechnology Vol 17, Issue 4 (2011) Exciting changes Yali Friedman Full details at the Journal of Commercial Biotechnology New technologies for neglected diseases: Can tax credits help [...]

Read the full article →

Where in the United States are drugs invented?

October 26, 2011

Following on the heels of my post on Globalization in the Pharmaceutical Industry, it is also useful to examine the distribution of inventorship across the United States. The stakes aren’t quite as high here — public health and national security don’t come in to play — but there still are important implications for economic development. [...]

Read the full article →

Pocket Biotechnology Industry Primer and Glossary

October 25, 2011

See larger image Pocket Biotechnology Industry Primer and Glossary (Kindle Edition) By (author) Friedman Yali List Price: $4.95 USD Release date September 22, 2011. I’ve just published the Pocket Biotechnology Industry Primer and Glossary as an ebook. This book, which was previously only available as a printed book, is now available in digital format, which [...]

Read the full article →

Where in the world are drugs invented? Measuring pharmaceutical globalization.

October 24, 2011

The global locations of drug invention are important for public health, economic development, and national security reasons. Inventors tend to focus on diseases endemic to where they live. This is one of the problems of neglected diseases — there are few/no researchers working on certain diseases, which can lead to significant public health problems. Drugs [...]

Read the full article →

Moving a foreign biotechnology company to the United States is easy as stealing in church

October 24, 2011

“What is the biggest challenge in moving a foreign biotechnology company to the United States?” I asked this question at the Delaware-New Jersey-Pennsylvania annual biotechnology conference and received a surprising response. The consensus was neatly stated by one of the panelists: “Moving to the US is like stealing in church.” For all the problems one [...]

Read the full article →

Now free: Conference on Breathing Additional Life into the Life Sciences

October 21, 2011

Thanks to a new sponsor, Breathing Additional Life into the Life Sciences is now free. The Journal of Commercial Biotechnology, published by thinkBiotech along with BiotechBlog, is proud to serve as a media sponsor for this upcoming conference on biotechnology development. Reaching the Next Milestone Conference on Breathing Additional Life into the Life Sciences Date: [...]

Read the full article →

Book Review: From Idea to Web Start-up in 21 Days: Creating bacn.com

October 20, 2011

See larger image From Idea to Web Start-up in 21 Days: Creating bacn.com (Voices That Matter) (Paperback) By (author) Jason Glaspey, Scott Kveton List Price: $29.99 USD New From: $9.09 In Stock Used from: $9.05 In Stock What does selling bacon on the Internet have to do with biotechnology business development? Almost nothing! But, that is [...]

Read the full article →

Pharmaceutical globalization: Where are drugs invented?

October 18, 2011

I’m back from the Filling the Pipeline conference in Boston, where I presented a talk on pharmaceutical globalization. Maintaining control of pharmaceutical drug innovation is key for national security, public health, and economic development. We know that much of late-stage development has gone overseas, but the question remains: Where are drugs invented? Using the DrugPatentWatch [...]

Read the full article →

Worldview on Biotechnology

October 17, 2011

NPR’s Moira Gunn recently interviewed Jeremy Abbate and I on the Scientific American Worldview project. Her interview, broadcast on Tech Nation, is now available at IT Conversations. For more details, you can also see our video interview and the Worldview website.

Read the full article →